Creatinine clearance and signs of end-organ damage in primary hypertension

Journal of Human Hypertension

Volumn 18, Issue 7, 2004, Pages 511-516

  Leoncini, G ^a   Viazzi, F ^a   Parodi, D ^a   Ratto, E ^a   Vettoretti, S ^a   Vaccaro, V ^a   Ravera, M ^a   Tomolillo, C ^a   Deferrari, G ^a   Pontremoli, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Creatinine clearance; Left ventricular hypertrophy; Retinopathy

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPHTHALMOSCOPY; ORGAN INJURY; PREVALENCE; RETINA BLOOD VESSEL; RETINOPATHY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN;

ADULT; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPHTHALMOSCOPY; PREVALENCE; RETINAL DISEASES; RETINAL VESSELS;

EID: 3543118852     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001689     Document Type: Article

References (25)

1. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 2001; 161: 886-891.
2. Jensen JS et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
3. Culleton BF et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219.
4. Kronenberg F et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105-115.
5. Fliser D et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
7. Ruilope LM et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225.
8. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation 1981; 23: 697-713.
9. Guidelines Committee. The sixth report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
10. Guidelines Subcommittee. World Health Organization/International Society of Hypertension (WHO/ISH) guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
11. Schouten EG, Vandenbroucke JP, van der Heide-Wessel C, van der Heide RM. Retinopathy as an independent indicator of all-causes mortality. Int J Epidemiol 1986; 15: 234-236.
12. Pontremoli R et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997; 30: 1135-1143.
13. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb reads. Am Heart J 1949; 37: 161-186.
14. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20: 1180-1186.
15. Keith NM, Wagener HP, Barker MW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336-345.
16. Shulman NB et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13: 180-193.
17. Pahor M et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998; 158: 1340-1345.
18. JF et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
19. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insight into old concepts. Clin Chem 1992; 38: 1933-1953.
20. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
21. Devereux RB et al. Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 1987; 9: 69-76.
22. Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs 1988; 35: 1-5.
23. Cuspidi C et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J 2001; 2: 702-706.
24. Wong TY et al. Retinal microvascular abnormalities and incident stroke; The Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134-1140.
25. Duncan BB et al. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002; 86: 1002-1006.